cephalexin has been researched along with enoxacin in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chodosh, S; Pizzuto, D; Tuck, J | 1 |
Hara, K; Izumikawa, K; Komori, M; Miyazaki, Y; Saito, A; Shigeno, Y; Suzuyama, Y; Watanabe, K; Yamaguchi, K; Yamashita, K | 1 |
2 trial(s) available for cephalexin and enoxacin
Article | Year |
---|---|
Comparative trials of doxycycline versus amoxicillin, cephalexin and enoxacin in bacterial infections in chronic bronchitis and asthma.
Topics: Adult; Amoxicillin; Asthma; Bacterial Infections; Bronchitis; Cephalexin; Clinical Trials as Topic; Doxycycline; Enoxacin; Female; Humans; Male; Middle Aged; Naphthyridines; Random Allocation; Sputum | 1988 |
[Comparative clinical study of enoxacin (AT-2266, ENX) and cefaclor (CCL) in chronic respiratory tract infections by a double-blind method].
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteria; Cefaclor; Cephalexin; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Enoxacin; Female; Humans; Male; Middle Aged; Naphthyridines; Respiratory Tract Infections | 1984 |
2 other study(ies) available for cephalexin and enoxacin
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |